<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: We investigated effects of renal function and <z:mp ids='MP_0002871'>albuminuria</z:mp> on cardiovascular outcomes in 9,795 low-risk patients with <z:mp ids='MP_0002055'>diabetes</z:mp> in the <z:chebi fb="0" ids="5001">Fenofibrate</z:chebi> Intervention and Event Lowering in <z:mp ids='MP_0002055'>Diabetes</z:mp> (FIELD) study </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Baseline and year 2 renal status were examined in relation to clinical and biochemical characteristics </plain></SENT>
<SENT sid="2" pm="."><plain>Outcomes included total <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>), cardiac and non-cardiac <z:hpo ids='HP_0011420'>death</z:hpo> over 5 years </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Lower estimated GFR (eGFR) vs eGFR ≥90 ml min⁻¹ 1.73 m⁻² was a risk factor for total <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> events: (HR [95% CI] 1.14 [1.01-1.29] for eGFR 60-89 ml min⁻¹ 1.73 m⁻²; 1.59 [1.28-1.98] for eGFR 30-59 ml min⁻¹ 1.73 m⁻²; p &lt; 0.001; adjusted for other characteristics) </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0002871'>Albuminuria</z:mp> increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk, with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> and macroalbuminuria increasing total <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (HR 1.25 [1.01-1.54] and 1.19 [0.76-1.85], respectively; p = 0.001 for trend) when eGFR ≥90 ml min⁻¹ 1.73 m⁻² </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk was further modified by renal status changes over the first 2 years </plain></SENT>
<SENT sid="6" pm="."><plain>In multivariable analysis, 77% of the effect of eGFR and 81% of the effect of albumin:<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio were accounted for by other variables, principally <z:hpo ids='HP_0003233'>low HDL-cholesterol</z:hpo> and elevated blood pressure </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS/INTERPRETATION: Reduced eGFR and <z:mp ids='MP_0002871'>albuminuria</z:mp> are independent risk factors for cardiovascular events and mortality rates in a low-risk population of mainly European ancestry </plain></SENT>
<SENT sid="8" pm="."><plain>While their independent contributions to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk appear small when other risk factors are considered, they remain excellent surrogate markers in clinical practice because they capture risk related to a number of other characteristics </plain></SENT>
<SENT sid="9" pm="."><plain>Therefore, both should be considered when assessing prognosis and treatment strategies in patients with <z:mp ids='MP_0002055'>diabetes</z:mp>, and both should be included in risk models </plain></SENT>
</text></document>